“We are flattening the curve in Ohio,” said Dr. Amy Acton, Ohio Department of Health Director.

At this time, there are no routinely available pharmaceutical products that are FDA-approved for the prevention or treatment of COVID-19.

This assessment will capture and curate best practices and lessons learned for off-site testing.

“This event was a great way to introduce all of us to the environment in which we hope to work,” says Dan.

Local authorities, hospital systems, and The Health Collaborative continue to explore strategies to increase local caches of supplies and equipment.